Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness.

6 de abril de 2015 atualizado por: US Department of Veterans Affairs

The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness

The purpose of this study is to learn how to help veterans play a stronger role in shaping their mental health care. Specifically we want to see if we can help veterans improve their mental health treatment by helping them decide if they want to involve family in their mental health treatment, and if so, how. The study will compare a "family member provider" program to an "enhanced treatment as usual approach" in achieving these goals.

Visão geral do estudo

Descrição detalhada

Previous research demonstrates that when families are active participants in the clinical care of persons with SMI, veterans experience improved outcomes, including treatment retention, vocational services participation, and empowerment. Numerous controlled trials show that when family involvement achieves the level of intensity and family psychoeducation (FPE), relapse rates are cut in half, and treatment adherence, clinical symptoms, and patient functioning are improved. However, despite these demonstrated benefits, rates of family involvement in the VA are unacceptably low. Even minimal family-clinician contact occurs for only one third of VA SMI patients, a lower rate than in non-VA systems of care. Therefore, it is not surprising that FPE, an intensive form of family-clinician contact, is almost never offered in the VA. In fact, a national VA survey conducted within the last three years indicated that 0% of VAs offer FPE programs conforming to EBP guidelines. Our previous experience further suggests that these deficits in care are due to combinations of provider, patient, and family factors, and that the VA presents specific challenges to implementing existing model programs, including FPE. We therefore believe it is necessary to approach the challenge of increasing family involvement in a step-wise fashion, first by engaging families in the processes of care, before trying to enlist them in more intensive programs such as FPE. Further, family engagement would likely be most effective if it builds on a foundation that empowers consumers to make informed choices regarding the involvement of relatives in care. Our group has developed and piloted a new, family-engagement approach that is gradual, patient-centered, recovery-based, and can address various barriers to improving care. It is manualized and thus replicable. The proposed study will implement and further evaluate this intervention, the brief Family Member Provider Outreach (FMPO).

Tipo de estudo

Intervencional

Inscrição (Real)

238

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • California
      • West Los Angeles, California, Estados Unidos, 90073
        • VA Greater Los Angeles Healthcare System, West Los Angeles, CA
    • Maryland
      • Baltimore, Maryland, Estados Unidos, 21201
        • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 70 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Age 18-70 years
  • Diagnosis of a psychotic disorder in keeping with criteria established by the Serious Mental Illness Treatment Research and Evaluation Center (SMITREC){{646}} (schizophrenic disorders (295.0-295.9), affective psychoses (296.1, 296.4-296.8) and other psychotic diagnoses (297.0-298.9)) or diagnosis of Major Depression with psychotic features (296.xx)
  • Decisional capacity to provide informed consent
  • At least two outpatient visits within last six months
  • At least monthly face-to-face contact for one hour or more with a patient-identified family member or caregiver
  • Assessment by the treating therapist or psychiatrist that the patient is clinically stable enough to participate in the program.

Family Member/Caregiver Inclusion Criteria

  • Age 18-80 years
  • Decisional capacity to provide informed consent
  • Permission from veteran to be contacted

Exclusion Criteria:

  • Patients whose families have attended the FPE group within the last six months
  • Patients whose families have had at least monthly clinician contact in the last six months
  • Patients who are currently homeless
  • Patients who participated in the FMPO pilot.

Family Member/Caregiver Exclusion Criteria:

  • Individuals who do not meet the inclusion criteria
  • Individuals who participated in the FMPO pilot.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: FMPO Condition
Family Member Provider Outreach is a brief recovery oriented model. THe FMPO meets with the consumer for 2-3 sessions and with the family for 2-3 sessions with the consumer's permission.
Family Member Provider Outreach is a brief recovery oriented model. THe FMPO meets with the consumer for 2-3 sessions and with the family for 2-3 sessions with the consumer's permission.
Comparador Ativo: Enhanced treatment as usual (e-TAU)
Enhanced treatment as usual. In this condition, the consumer is given a list of family services available including the family intervention team.
Enhanced treatment as usual. In this condition, the consumer is given a list of family services available including the family intervention team.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Family-Clinician Contact (Including Contact With FMPO Clinician)
Prazo: Within 6 months of intervention
Chart review looking at the any clinician contact with veteran's family members
Within 6 months of intervention
Family-Clinician Contact (Not Including Notes From FMPO Clinicians)
Prazo: Within 6 months of intervention
Chart review looking at the any clinician contact with veteran's family members
Within 6 months of intervention

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Consumer's Recovery Rating - MHRM Total Score
Prazo: Within 6 months of intervention
We measured recovery attitudes and beliefs with the Mental Health Recovery Measure (MHRM), a 30-item self-report measure that has a total score and eight subscales.The MHRM scales range from 0-120, with a higher score indicating better recovery.
Within 6 months of intervention
Consumer's Recovery Rating - MHRM - Overcoming Stuckness Sub Score
Prazo: Within 6 month of the intervention
We measured recovery attitudes and beliefs with the Mental Health Recovery Measure (MHRM), a 30-item self-report measure that has a total score and eight subscales. This sub score is Overcoming Stuckness.The MHRM sub scales range from 0-16, with a higher score indicating better recovery.
Within 6 month of the intervention

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Lisa B Dixon, MD MPH, Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo

1 de setembro de 2007

Conclusão Primária (Real)

1 de maio de 2011

Conclusão do estudo (Real)

1 de junho de 2011

Datas de inscrição no estudo

Enviado pela primeira vez

24 de abril de 2007

Enviado pela primeira vez que atendeu aos critérios de CQ

25 de abril de 2007

Primeira postagem (Estimativa)

27 de abril de 2007

Atualizações de registro de estudo

Última Atualização Postada (Estimativa)

24 de abril de 2015

Última atualização enviada que atendeu aos critérios de controle de qualidade

6 de abril de 2015

Última verificação

1 de agosto de 2014

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • IIR 04-255
  • H-28791 (Outro identificador: UMB IRB)

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever